The number of people with susceptibility test result for rifampicin in France
France: The number of people with susceptibility test result for rifampicin was 1.45 in 2021. ◆ Volatile
Latest (2021)
1.45
Change on year
down 22.6%
World rank
141st
of 146 countries
All-time high
217.8
in 2018
All-time low
1.45
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in France, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
France recorded 1.45 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
The figure is down 22.6% on the previous year and down 99.2% over five years.
That places France 141st out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in France, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 193.24 | — |
| 2018 | 217.8 | +12.7% |
| 2019 | 1.62 | -99.3% |
| 2020 | 1.88 | +15.9% |
| 2021 | 1.45 | -22.6% |
France compared with similar countries
- France's 1.45 is below the median for high income countries, which is 92.6, 2% of the median. (56 countries reporting)
- France's 1.45 is below the median for Europe & Central Asia, which is 93.52, 2% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 137.55 | 1.62 | 217.8 | 3 |
| 2020s | 1.66 | 1.45 | 1.88 | 2 |
Countries ranked near France
- 138 Niger 11.2 compare
- 139 Central African Republic 9.75 compare
- 140 Venezuela, Bolivarian Republic of 3.31 compare
- 142 South Sudan 0 compare
- 142 Grenada 0 compare
- 142 Sao Tome and Principe 0 compare
- 142 Vanuatu 0 compare
- 142 Mauritania 0 compare
More health data for France
- Un projection of annual infant deaths, annual growth rate -1.31 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0689 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,016 deaths per 1,000 people (2090)
- Number of infants who die before age 1 603 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -0.7875 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0244 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8291 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in France?
- The number of people with susceptibility test result for rifampicin in France was 1.45 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in France?
- The highest recorded value was 217.8 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in France?
- The lowest recorded value was 1.45 in 2021.
- How does France rank for the number of people with susceptibility test result for rifampicin?
- France ranks 141st out of 146 countries with data for 2021.
- Where does this France data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).